Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2013

Open Access 01-01-2013 | Original Paper

Exploring ART Intake Scenes in a Human Rights-Based Intervention to Improve Adherence: A Randomized Controlled Trial

Authors: Cáritas Relva Basso, Ernani Tiaraju Santa Helena, Joselita Maria Magalhães Caraciolo, Vera Paiva, Maria Ines Battistela Nemes

Published in: AIDS and Behavior | Issue 1/2013

Login to get access

Abstract

To assess the effectiveness of a psychosocial individual intervention to improve adherence to ART in a Brazilian reference-center, consenting PLHIV with viral load >50 copies/ml were selected. After 4 weeks of MEMS cap use, participants were randomized into an intervention group (IG) (n = 64) or control group (CG) (n = 57). CG received usual care only. The IG participated in a human rights-based intervention approach entailing four dialogical meetings focused on medication intake scenes. Comparison between IG and CG revealed no statistically significant difference in adherence measured at weeks 8, 12, 16, 20 and 24. Viral load (VL) decreased in both groups (p < 0.0001) with no significant difference between study groups. The lower number of eligible patients than expected underpowered the study. Ongoing qualitative analysis should provide deeper understanding of the trial results. NIH Clinical Trials: NCTOO716040.
Footnotes
1
For a deeper understanding of Brazilian Unified Health System see the Lancet The Brazil Series that critically examines what the country's policies have achieved and where future challenges might lie, accessible at http://​www.​thelancet.​com/​series.
 
Literature
1.
Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef
2.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMed
3.
Bangsberg DR. Less than 95 % adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939–41.PubMedCrossRef
4.
FeA Acurcio, Puig-Junoy J, Bonolo PeF, Braga Ceccato MG, Guimarães MD. Cost-effectiveness of initial adherence to antiretroviral therapy among HIV infected patients in Belo Horizonte, Brazil. Rev Esp Salud Publica. 2006;80(1):41–54.CrossRef
5.
Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115(8):632–41.PubMedCrossRef
6.
Munakata J, Benner JS, Becker S, Dezii CM, Hazard EH, Tierce JC. Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus. Med Care. 2006;44(10):893–9.PubMedCrossRef
7.
Lamiraud K, Moatti JP. Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients. Expert Opin Pharmacother. 2006;7(2):135–43.PubMedCrossRef
8.
Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.PubMedCrossRef
9.
Wahl LM, Nowak MA. Adherence and drug resistance: predictions for therapy outcome. Proc Biol Sci. 2000;267(1445):835–43.PubMedCrossRef
10.
Nemes MIB, Beaudoin J, Conway S, Kivumbi GW, Skjelmerud A, Vogel U. Evaluation of WHO’s contribution to “3 by 5”: main report. Geneva: World Health Organization, 2006.
11.
Bennett S, Chanfreau C. Approaches to rationing antiretroviral treatment: ethical and equity implications. Bull World Health Organ. 2005;83(7):541–7.PubMed
12.
Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef
13.
WHO. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
14.
Ministério da Saúde. Diretrizes para o fortalecimento das ações de adesão ao tratamento para pessoas que vivem com HIV e Aids. In: Coordenação Nacional de DST/Aids, editor. Brasília. Brasil: Ministério da Saúde 2008.
15.
Caraciolo JMM, Santa Helena ET, Basso CR, Souza RA, Silva MH, Adão VM, et al. Intervention to enhance HAART adherence in HIV/Aids health services in the State of São Paulo, Brazil, 2007. Saude Soc. 2009;18 suppl 2:78–93.
16.
Garcia R, Pondé M, Lima M, Souza AR, Stolze SM, Badaró R. Lack of effect of motivation on the adherence of HIV-positive/AIDS patients to antiretroviral treatment. Braz J Infect Dis. 2005;9(6):494–9.PubMedCrossRef
17.
Gupta N, Silva AC, Passos LN. The role of integrated home-based care in patient adherence to antiretroviral therapy. Rev Soc Bras Med Trop. 2005;38(3):241–5.PubMedCrossRef
18.
Sampaio-Sa M, Page-Shafer K, Bangsberg DR, Evans J, Dourado Mde L, Teixeira C, et al. 100 % adherence study: educational workshops versus video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav. 2008;12(Suppl 4):S54–62.PubMedCrossRef
19.
Berkman A, Garcia J, Munoz-Laboy M, Paiva V, Parker R. A critical analysis of the Brazilian response to HIV/AIDS: lessons for controlling and mitigating the epidemic in developing countries. Am J Public Health. 2005;95(7):1162–72.PubMedCrossRef
20.
Paim J, Travassos C, Almeida C, Bahia Ligia, Macinko J. The Brazilian health system: history, advances and challenges. Lancet. 2011;377(9779):1778–97.PubMedCrossRef
21.
Mann J, Tarantola D, editors. AIDS in the world II. New York: Oxford University Press; 1996.
22.
Ayres JRCM, Paiva V, França JR I. From natural history of disease to vulnerability: changing concepts and practices in contemporary public health. In: Sommer RPaM, editor. Routledge Handbook in Global Public Health. 1 edition ed. Abingdon, Oxon: T & F Books; 2011. p. 98–107.
23.
Ayres J. Access to AIDS treatment: appropriateness and correctness in the pursuit of good practice. Cad Saude Publica. 2006;22(4):705–31.CrossRef
24.
Gruskin S, Tarantola D. Universal Access to HIV prevention, treatment and care: assessing the inclusion of human rights in international and national strategic plans. AIDS. 2008;22(Suppl 2):S123–32.PubMedCrossRef
25.
Kalichman A, Diniz S. AIDS treatment in Brazil: what kind of evidence do we need? Lancet. 2009;374(969):1066.PubMedCrossRef
26.
Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS. 2004;18(Suppl 3):S15–20.PubMedCrossRef
27.
Paiva V, Teixeira P, Shimma E. What is being done to improve ARV therapy in São Paulo, Brazil. XIII International AIDS Conference; Durban: Marathon Multimidia; 2000.
28.
Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006;3:CD001442.
29.
Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef
30.
Nemes M, Helena E, Caraciolo J, Basso C. Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches. Cad Saude Publica. 2009;25:S392–400.PubMedCrossRef
31.
Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17(3):269–76.PubMedCrossRef
32.
Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns. 1995;26(1–3):139–44.PubMedCrossRef
33.
Britain. RPSoG. From compliance to concordance: toward shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain; 1997.
34.
Ayres JRCM, Paiva V, França I Jr, Silva NGd, Lacerda R, Negra MD, et al. Vulnerability, human rights, and comprehensive health care needs of young people living with HIV/AIDS. Am J Public Health. 2006;96:1001–6.PubMedCrossRef
35.
Paiva V, Ayres J, Grusking S. Being young and living with HIV: the double neglect of sexual citizenship. Routledge Handbook of Sexuality, Health and Rights. New York: Taylor & Francis Group; 2010. p. 422–430.
36.
Paiva V, Ayres J, França I Jr. Expanding the flexibility of normative patterns in youth sexuality and prevention and care programs. In: Sexuality Research & Social Policy. Journal of NCRC Access at http://​nsrc.​sfsu.​edu. 2004;1 Suppl 1.
37.
Ayres JR. O cuidado, os modos de ser (do) humano e as práticas de saúde. Saude Soc. 2004;13(3):16–29.CrossRef
38.
Benzaken A, Galban Garcia E, Sardinha J, Paiva V. Community-based intervention to control STD/AIDS in the Amazon region, Brazil. Rev Saude Publica. 2007;41:118–26.PubMedCrossRef
39.
Paiva V, Garcia J, Rios L, Santos A, Terto V, Munõz-Laboy. Religious communities and HIV prevention: an intervention study using a human rights-based approach. Health. GP, editor. 2010.
40.
Paiva V. Analysing sexual experiences through “scenes”: a framework for the evaluation of sexuality education. Sex Educ. 2005;5(Suppl 4):345–58.CrossRef
41.
WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendation for a public health approach. In: HTM/HIV, editor. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2006 rev.
42.
Freire P. Pedagogy of the oppressed. 30th ed. New York: The continuum International Publishing Group Inc; 2006. p. 195.
43.
Anggleton P, Parker R (Org). Routledge Handbook of Sexuality, Health and Rights. 1 ed. New York: Taylor & Francis Group; 2010.
44.
Parker R, Aggleton P. Introduction. Sexuality, Culture and Health. Routledge Handbook of Sexuality, Health and Rights. 2nd edition. New York. 2007. p. 1-13.
45.
Paiva V. Gendered scripts and the sexual scenes: promoting sexual subjects among Brazilians teenagers. In: Aggleton RPP, editor. Sexuality, Culture and Health. 2nd ed. New York: Taylor & Francis Group; 2007. p. 427–43.
46.
Maluwa M, P’ A. RG. P. HIV and AIDS-related stigma, discrimination and human rights. A critical overview. Health and Human Rights. 2002;6(1):1–18.CrossRef
47.
Parker RG, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24.PubMedCrossRef
48.
Garrido PB, Paiva V, do Nascimento VL, Sousa JB, Santos NJ. AIDS, stigma and unemployment: implications for health services. Rev Saude Publica. 2007;41(Suppl 2):72–9.PubMed
49.
Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S103–6.PubMedCrossRef
50.
Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007;63(12):1115–21.PubMedCrossRef
51.
Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59(1):56–66.PubMedCrossRef
52.
Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis. 2006;42(11):1619–27.PubMedCrossRef
53.
Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20(9):1295–302.PubMedCrossRef
54.
Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA, Team NIoMHHLP. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574–80.PubMedCrossRef
55.
Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16 Suppl 2:CD000011.
56.
Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedCrossRef
57.
van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:55.PubMedCrossRef
58.
Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA. The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS. 1999;13(7):797–804.PubMedCrossRef
59.
Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93–108.PubMedCrossRef
60.
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–79.PubMedCrossRef
61.
Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624–32.PubMedCrossRef
Metadata
Title
Exploring ART Intake Scenes in a Human Rights-Based Intervention to Improve Adherence: A Randomized Controlled Trial
Authors
Cáritas Relva Basso
Ernani Tiaraju Santa Helena
Joselita Maria Magalhães Caraciolo
Vera Paiva
Maria Ines Battistela Nemes
Publication date
01-01-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0175-4

Other articles of this Issue 1/2013

AIDS and Behavior 1/2013 Go to the issue

Original Paper

Assessing HIV/AIDS Stigma in South India: Validation and Abridgement of the Berger HIV Stigma Scale

Original Paper

Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV

Original Paper

The Relationship Between Perceived Discrimination and High-Risk Social Ties Among Illicit Drug Users in New York City, 2006–2009

Original Paper

Patterns of HIV Disclosure and Condom Use Among HIV-Infected Young Racial/Ethnic Minority Men Who Have Sex with Men

Substantive Review

Predictors of Late Presentation for HIV Diagnosis: A Literature Review and Suggested Way Forward

Original Paper

Antiretroviral Adherence Among Rural Compared to Urban Veterans with HIV Infection in the United States
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits